Cargando…

PPWD1 is associated with the occurrence of postmenopausal osteoporosis as determined by weighted gene co-expression network analysis

Postmenopausal osteoporosis (PMO) is the most common type of primary osteoporosis (OP), a systemic skeletal disease. Although many factors have been revealed to contribute to the occurrence of PMO, specific biomarkers for the early diagnosis and therapy of PMO are not available. In the present study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Guo-Feng, Yuan, Lu-Shun, Chen, Min, Ye, Dan, Chen, Guo-Ping, Zhang, Zhe, Li, Cheng-Jiang, Vijayan, Vijith, Xiao, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755193/ https://www.ncbi.nlm.nih.gov/pubmed/31432133 http://dx.doi.org/10.3892/mmr.2019.10570

Ejemplares similares

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Long non-coding RNA RP11-284F21.9 functions as a ceRNA regulating PPWD1 by competitively binding to miR-769-3p in cervical carcinoma
por: Han, Hong-Fang, et al.
Publicado: (2020)

Determinants of imminent fracture risk in postmenopausal women with osteoporosis
por: Barron, R. L., et al.
Publicado: (2020)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Association between Postmenopausal Osteoporosis and Experimental Periodontitis
por: Luo, Kai, et al.
Publicado: (2014)

Cognitive determinants of weight control by dietary patterns among postmenopausal women with osteoporosis: An application of theory of planned behavior
por: Hajizadeh, Hossein, et al.
Publicado: (2021)

Depression, Quality of Life, and Self-Esteem of Moroccan Postmenopausal Women with Osteoporosis before the Occurrence of Fractures
por: Bahouq, Hanane, et al.
Publicado: (2020)

Gingival recession in postmenopausal women with and without osteoporosis
por: DUNCEA, IOANA, et al.
Publicado: (2013)

Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
por: Wang, Han, et al.
Publicado: (2023)

Analysis of potential genetic biomarkers and molecular mechanism of smoking-related postmenopausal osteoporosis using weighted gene co-expression network analysis and machine learning
por: Li, Shaoshuo, et al.
Publicado: (2021)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Network pharmacology explores the mechanisms of Eucommia ulmoides cortex against postmenopausal osteoporosis
por: Shao, Yan, et al.
Publicado: (2022)

Potential mechanism of Ziyin Tongluo Formula in the treatment of postmenopausal osteoporosis: based on network pharmacology and ovariectomized rat model
por: Chen, Rong-Bin, et al.
Publicado: (2021)

MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis
por: He, Yuehui, et al.
Publicado: (2021)

Potential diagnostic value of PD‐1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients
por: Cai, Xiu‐Ping, et al.
Publicado: (2020)

The occurrence and development of vertebral osteoporosis regulated by IL-8
por: Zhu, Hao, et al.
Publicado: (2023)

Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis
por: Fan, Wei, et al.
Publicado: (2023)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Introduction to the Guidelines on Menopause and Postmenopausal Osteoporosis
por: Meeta, Meeta
Publicado: (2020)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Long-Term Treatment of Postmenopausal Osteoporosis
por: Brown, Jacques P.
Publicado: (2021)

T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
por: Wu, Di, et al.
Publicado: (2021)

Anabolic treatments for osteoporosis in postmenopausal women
por: Hassan, Neelam, et al.
Publicado: (2021)

Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis
por: Liu, Huilan, et al.
Publicado: (2022)

Postmenopausal Osteoporosis: A Literature Review
por: Bhatnagar, Aayushi, et al.
Publicado: (2022)

The role of melatonin in the development of postmenopausal osteoporosis
por: Yang, Keda, et al.
Publicado: (2022)

The prevalence and treatment rate trends of osteoporosis in postmenopausal women
por: Zhang, Xiaojuan, et al.
Publicado: (2023)

Hub genes and gene functions associated with postmenopausal osteoporosis predicted by an integrated method
por: Cao, Honghai, et al.
Publicado: (2019)

Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis
por: Wang, Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kaf9j25f2vi1ee298ab23quj62